Dear ladies and gentlemen,
dear colleagues,

everybody is suffering from the Corona crisis at this point of time. The decision whether the Annual Meeting of the American Society of Clinical Oncology (ASCO) is being held in Chicago from May 29th to June 2nd, 2020, has not been made by now. Eventually the ASCO meeting 2020 will be replaced by a virtual meeting since thousands of abstracts have already been submitted to the ASCO program committee.

Because there are almost 6 weeks between the ASCO meeting and our European Post-Chicago Meeting in Munich, we are still hoping for a face-to-face meeting in Munich for giving us the opportunity to discuss the latest news on skin cancer with an outstandingly renown faculty onsite in Munich. However, if there are no new data available (if neither an onsite meeting in Chicago nor a virtual ASCO meeting is presented) or if travel and public life is still restricted, we are aiming on a postponement of our Post-Chicago meeting to October 2020 in Munich.

We will update you on our website accordingly.

Take care and best wishes for all of you!
Axel Hauschild (Kiel) & Claus Garbe (Tübingen) and the MedConcept team

WELCOME

Dear colleagues and friends,

The first Post-Chicago Meeting on Melanoma / Skin Cancer took place 2011. In 2019, the meeting has attracted more than 700 participants from 34 countries. The interactive congress offers a comprehensive overview on all new developments in melanoma diagnostics and therapy and a direct communication with the world’s leading experts in these fields.

The aim of the Interdisciplinary Global Conference on News in Melanoma/ Skin Cancer in Munich is to grant a deep overall insight into the development of new drugs for melanoma and other cutaneous malignancies. The lively interaction of clinicians, as well as experts in translational and basic research, and representatives of the pharmaceutical industry, guarantees a successful outcome for every participant.

International key opinion leaders on melanoma will be invited to give an overview throughout specified presentations, to present latest clinical trial results, and to discuss on exciting new drugs with the audience. In addition to the scientific value of this meeting, every participant may seize the given opportunity to interact with experts in a familiar setting in one of the most interesting cities of Germany.

Please join us for this event and submit your own studies and case presentations as free communications and as posters.

We look forward to welcoming you in Munich in July 2020!

Axel Hauschild, MD          Claus Garbe, MD
Congress Presidents